日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biological Activity and Structural Biology of Current KAT6A Inhibitor Chemotypes.

当前KAT6A抑制剂化学类型的生物活性和结构生物学。

Suwandi Adi, Jin Jianwen, Zhao Yichao, Mudududdla Ramesh, Gee Yi Sing, Deora Girdhar Singh, Sun Yuxin, Wei Heping, Huang Fei, He Jin-Shu, George Amee J, Hermans Stefan J, Leaver David J, Parker Michael W, Baell Jonathan B

Dynamic changes in brain network functional connectivity following repositioning treatment for benign paroxysmal positional vertigo: an fNIRS study

良性阵发性位置性眩晕患者接受体位调整治疗后脑网络功能连接的动态变化:一项近红外光谱研究

Xiao, Junhua; Pan, Qingchun; Huang, Renli; Jin, Shu

Molecular mechanism of gallium nitrate in inhibiting bacterial biofilm formation through pykF modulation

硝酸镓通过调控pykF抑制细菌生物膜形成的分子机制

Zhang, Xiaofeng; Dong, Junjie; Wang, Bing; Chen, Lingqiang; Gong, Zhiqiang; Yang, Jin; Shu, Guizhao; Ning, Qi

Predictive value of multimodal functional magnetic resonance imaging for cognitive impairment in patients with non-dialysis chronic kidney disease

多模态功能磁共振成像对非透析慢性肾脏病患者认知障碍的预测价值

Han, Zhe; Xu, Xia; Jia, Mengxue; Liu, Wenjin; Zhu, Yijiao; Jin, Shu; Liu, Yushuang; Li, Hongxia; Bi, Guangyu; Wang, Rong

Ring finger protein 10 is atherosclerosis protective and modulates macrophage polarization

环指蛋白10具有动脉粥样硬化保护作用,并调节巨噬细胞极化。

Zhao, Ke-Xin; Jin, Shu-Xu; Li, Ming-Hao

Pulsed-Field Ablation of Atrial Tachycardia Originating From Bachmann's Bundle Via Epicardial Approach

经心外膜入路脉冲场消融术治疗起源于巴赫曼束的心房性心动过速

Jin, Shu-Yu; Liu, Tong; Long, De-Yong

Pulsed-Field Ablation of Atrial Tachycardia Arising From the Noncoronary Sinus of Valsalva

脉冲场消融术治疗起源于非冠状动脉窦的房性心动过速

Jiang, Chen-Xi; Jin, Shu-Yu; Lin, Jing; Long, De-Yong

Post-modulation of layer-by-layer assemblies coordinated by a catalytic dose of fullerene derivatives without external fields

无需外加场,即可通过催化剂量的富勒烯衍生物协调层层组装体的后调控。

Geng, Bi-Jun; Li, Yun-Fei; Deng, Lin-Long; Diao, Tong-Ruo; Ma, Zi-Wei; Lin, Long-Xing; Li, Jin-Shu; Yan, Yi-Dong; Yan, Jia-Wei; Tan, Yuan-Zhi; Mao, Bing-Wei; Xie, Su-Yuan; Tian, Zhong-Qun; Yang, Yang

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer

纳武利尤单抗和瑞拉利单抗用于治疗不可切除或转移性错配修复功能正常的结直肠癌患者

Christenson, Eric S; Ho, Won Jin; Shu, Daniel; Durham, Jennifer N; Brancati, Madelena; Davis Bruning, Heather; Petrie, Susan; Wang, Hao; Lu, Jiayun; Bever, Katherine M; Laheru, Daniel; de Jesus-Acosta, Ana; Browner, Ilene; Donehower, Ross; Pishvaian, Michael J; Azad, Nilofer; Zhu, Qingfeng; Valentin, Alens; Suresh Babu, Jayalaxmi; Hernandez, Alexei; Apostol, George; Gao, Yiyang; Llosa, Nicolas; Housseau, Franck; Pardoll, Drew; Jaffee, Elizabeth M; Anders, Robert; Le, Dung T

Correction: CXCL13 suppresses liver regeneration through the negative regulation of HGF signaling

更正:CXCL13通过负调控HGF信号通路抑制肝脏再生。

Zhao, Qun; Wu, Jingyi; Feng, Mengyuan; Zhang, Anjie; Fu, Liwei; Chen, Jinglin; Li, Lian; Li, Fangzhou; Li, Tingting; Jin, Shu; Li, Shengbao; Yu, Xianjun